These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28643153)

  • 41. Near-Infrared Molecular Imaging of Glioblastoma by Miltuximab
    Polikarpov DM; Campbell DH; McRobb LS; Wu J; Lund ME; Lu Y; Deyev SM; Davidson AS; Walsh BJ; Zvyagin AV; Gillatt DA
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32316186
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeting cancer stem cells with an 131I-labeled anti-AC133 monoclonal antibody in human colorectal cancer xenografts.
    Lang J; Lan X; Liu Y; Jin X; Wu T; Sun X; Wen Q; An R
    Nucl Med Biol; 2015 May; 42(5):505-512. PubMed ID: 25669587
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Novel ¹¹¹In-Labeled Anti-Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer.
    Chatalic KL; Veldhoven-Zweistra J; Bolkestein M; Hoeben S; Koning GA; Boerman OC; de Jong M; van Weerden WM
    J Nucl Med; 2015 Jul; 56(7):1094-9. PubMed ID: 25977460
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-colorectal cancer effects of anti-p21Ras scFv delivered by the recombinant adenovirus KGHV500 and cytokine-induced killer cells.
    Liu FR; Bai S; Feng Q; Pan XY; Song SL; Fang H; Cui J; Yang JL
    BMC Cancer; 2018 Nov; 18(1):1087. PubMed ID: 30419845
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immuno-PET of human colon xenograft- bearing BALB/c nude mice using 124I-CDR-grafted humanized A33 monoclonal antibody.
    Lee FT; Hall C; Rigopoulos A; Zweit J; Pathmaraj K; O'Keefe GJ; Smyth FE; Welt S; Old LJ; Scott AM
    J Nucl Med; 2001 May; 42(5):764-9. PubMed ID: 11337573
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Generation and characterization of a target-selectively activated antibody against epidermal growth factor receptor with enhanced anti-tumor potency.
    Yang Y; Guo Q; Xia M; Li Y; Peng X; Liu T; Tong X; Xu J; Guo H; Qian W; Hou S; Dai J; Wang H; Liu R; Guo Y
    MAbs; 2015; 7(2):440-50. PubMed ID: 25679409
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rapid optical imaging of EGF receptor expression with a single-chain antibody SNAP-tag fusion protein.
    Kampmeier F; Niesen J; Koers A; Ribbert M; Brecht A; Fischer R; Kiessling F; Barth S; Thepen T
    Eur J Nucl Med Mol Imaging; 2010 Oct; 37(10):1926-34. PubMed ID: 20449589
    [TBL] [Abstract][Full Text] [Related]  

  • 48. rNAPc2 inhibits colorectal cancer in mice through tissue factor.
    Zhao J; Aguilar G; Palencia S; Newton E; Abo A
    Clin Cancer Res; 2009 Jan; 15(1):208-16. PubMed ID: 19118048
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antitumor effects of an engineered and energized fusion protein consisting of an anti-CD20 scFv fragment and lidamycin.
    Fang H; Miao Q; Zhang S; Cheng X; Xiong D; Zhen Y
    Sci China Life Sci; 2011 Mar; 54(3):255-62. PubMed ID: 21416325
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of a CEACAM5 targeted nanobody for positron emission tomography imaging and near-infrared fluorescence imaging of colorectal cancer.
    Xiao Y; Mei C; Xu D; Yang F; Yang M; Bi L; Mao J; Pang P; Li D
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2305-2318. PubMed ID: 36914753
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
    Wang X; Campoli M; Ko E; Luo W; Ferrone S
    J Immunol Methods; 2004 Nov; 294(1-2):23-35. PubMed ID: 15604013
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structural and functional characterization of MBS301, an afucosylated bispecific anti-HER2 antibody.
    Huang S; Li F; Liu H; Ye P; Fan X; Yuan X; Wu Z; Chen J; Jin C; Shen B; Feng J; Zhang B
    MAbs; 2018; 10(6):864-875. PubMed ID: 30081724
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Production of soluble ScFvs with C-terminal-free thiol for site-specific conjugation or stable dimeric ScFvs on demand.
    Albrecht H; Burke PA; Natarajan A; Xiong CY; Kalicinsky M; DeNardo GL; DeNardo SJ
    Bioconjug Chem; 2004; 15(1):16-26. PubMed ID: 14733579
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preliminary radioimmunoimaging and biodistribution of ¹³¹iodine-labeled single-chain antibody fragment against progastrin-releasing peptide(₃₁₋₉₈) in small cell lung cancer xenografts.
    Hong Z; Shi Y; Liu Z; Zhou X; Yang Y; Tang J
    Chin Med J (Engl); 2014; 127(11):2007-11. PubMed ID: 24890142
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improved tumor targeting with chemically cross-linked recombinant antibody fragments.
    King DJ; Turner A; Farnsworth AP; Adair JR; Owens RJ; Pedley RB; Baldock D; Proudfoot KA; Lawson AD; Beeley NR
    Cancer Res; 1994 Dec; 54(23):6176-85. PubMed ID: 7954464
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthetic human monoclonal antibody targets hIL1 receptor accessory protein chain with therapeutic potential in triple-negative breast cancer.
    Zheng P; Zhang Y; Zhang B; Wang Y; Wang Y; Yang L
    Biomed Pharmacother; 2018 Nov; 107():1064-1073. PubMed ID: 30257318
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo targeting of malignant melanoma by 125Iodine- and 99mTechnetium-labeled single-chain Fv fragments against high molecular weight melanoma-associated antigen.
    Kang N; Hamilton S; Odili J; Wilson G; Kupsch J
    Clin Cancer Res; 2000 Dec; 6(12):4921-31. PubMed ID: 11156253
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In Vivo HER2-Targeted Magnetic Resonance Tumor Imaging Using Iron Oxide Nanoparticles Conjugated with Anti-HER2 Fragment Antibody.
    Ding N; Sano K; Kanazaki K; Ohashi M; Deguchi J; Kanada Y; Ono M; Saji H
    Mol Imaging Biol; 2016 Dec; 18(6):870-876. PubMed ID: 27351762
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Eradication of growth of HER2-positive ovarian cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate in mouse xenograft model.
    Yu L; Wang Y; Yao Y; Li W; Lai Q; Li J; Zhou Y; Kang T; Xie Y; Wu Y; Chen X; Yi C; Gou L; Yang J
    Int J Gynecol Cancer; 2014 Sep; 24(7):1158-64. PubMed ID: 24987913
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combination of novel DR5 targeting agonistic scFv antibody TR2-3 with cisplatin shows enhanced synergistic antitumor activity in vitro and in vivo.
    Lei G; Xu M; Xu Z; Lu C; Tan S
    Biomed Pharmacother; 2018 Feb; 98():271-279. PubMed ID: 29272788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.